Assessment of effectiveness and safety of biosimilar infliximab (CT-P13) in a real-life setting for treatment of patients with active rheumatoid arthritis or ankylosing spondylitis

Cătălin Codreanu, Klára Šírová, Katerina Jarošová, Anastas Batalov
  • Current Medical Research and Opinion, April 2018, Taylor & Francis
  • DOI: 10.1080/03007995.2018.1441144
The author haven't yet claimed this publicationThe author haven't yet claimed this publication
Read Publication

http://dx.doi.org/10.1080/03007995.2018.1441144

In partnership with: